Welcome to an office-based treatment that can restore* bladder function and quality of life for your OAB patients — without the side effects of medications† or potential self-catheterization.‡,1
The Medtronic NURO™ system delivers electrical pulses through a needle to stimulate the afferent fibers of the tibial nerve that runs posterior to the medial malleolus and extends to the sacral nerve plexus. This treatment is called Percutaneous Tibial Neuromodulation (PTNM), otherwise known as Percutaneous Tibial Neurostimulation (PTNS).
The NURO system is easy to use and manage in almost any practice setting.
Restored bladder function is defined as a measurable reduction in urinary frequency and/or urinary incontinence episodes following treatment.
Most common side effects of PTNM are temporary and include mild pain or skin inflammation at or near the stimulation site.
While the NURO device was not used in the studies cited here, since it delivers equivalent stimulation therapy as the device used in the studies, a user can expect similar performance.
Peters, K. M., S. A. Macdiarmid, et al. (2009). Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol 182(3): 1055-1061.